4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-25-090428
Chief Executive Officer sold 26,491 shares at $6.80 ($180,139)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2025-06-25 | Sale 10b5-1 | −26,491 | $6.80 | $180,139 | 830,065 | D: show line 1 in the form |
| Open-market sales · 26,491 sh · avg $6.80 · $180,139 | |||||||
Loading xslF345X05/ownership.xml…